BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu K, Cui J, Zhan Y, Ouyang Q, Lu Q, Yang D, Li X, Yin J. Reprogramming the tumor microenvironment by genome editing for precision cancer therapy. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01561-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xiong X, Xie X, Wang Z, Zhang Y, Wang L. Tumor-associated macrophages in lymphoma: From mechanisms to therapy. International Immunopharmacology 2022;112:109235. [DOI: 10.1016/j.intimp.2022.109235] [Reference Citation Analysis]
2 Zhou C, Li C, Zheng Y, Huang X. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.934076] [Reference Citation Analysis]
3 Zhu X, Zhu J, Chen Y, Liu Y, Lu J, Sun J, Peng S, Chen M, Du Y. Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma. Front Oncol 2022;12:972744. [DOI: 10.3389/fonc.2022.972744] [Reference Citation Analysis]
4 Hejabi F, Abbaszadeh MS, Taji S, O’neill A, Farjadian F, Doroudian M. Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems. Front Chem 2022;10:957572. [DOI: 10.3389/fchem.2022.957572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]